Lilly To Inject $1B In New Manufacturing Facility In North Carolina, US Eli Lilly And Co (NYSE: LLY) Benzinga · Jan 28, 2022
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report Eli Lilly And Co (NYSE: LLY) plans to invest more than €400 million into a new manufacturing facility in Limerick, Ireland, according to a Benzinga · Jan 28, 2022
Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to Benzinga · Jan 28, 2022
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against the Omicron variant of COVID-19 and their emergency use authorization has been rescin Benzinga · Jan 25, 2022
Abbisko, Lilly Ink Licensing Pact For Cardiometabolic Diseases Abbisko Therapeutics has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly And Co (NYSE: LLY) for novel molecules against an Benzinga · Jan 18, 2022